Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144388 (US8969376, 1.002 (3/2 HCl)) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.00450 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144415 (US8969376, 1.152) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.00680 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144408 (US8969376, 1.112) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.00850 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144399 (US8969376, 1.050) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0190 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144405 (US8969376, 1.097) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0350 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144409 (US8969376, 1.114) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0440 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144398 (US8969376, 1.047) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0450 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144397 (US8969376, 1.031) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0520 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144390 (US8969376, 1.006) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144394 (US8969376, 1.013) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0900 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144387 (US8969376, 1.001 (HCl)) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.110 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144396 (US8969376, 1.027) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.130 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144410 (US8969376, 1.123) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.150 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144411 (US8969376, 1.126) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.170 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144404 (US8969376, 1.085) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.180 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144391 (US8969376, 1.009) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144393 (US8969376, 1.011) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.220 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144412 (US8969376, 1.133) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144401 (US8969376, 1.059) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164395 (US9669029, 98 8-Methoxy-5-methyl-2-{2-[1-(2-morpho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.330 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144427 (US8969376, 2.001) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.360 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144392 (US8969376, 1.010 (HCl)) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.380 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144403 (US8969376, 1.081) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164399 (US9669029, 102 5,8-Dimethyl-2-[2-(1-methyl-4-thiop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144414 (US8969376, 1.147) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164544 (US9669029, 115 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164545 (US9669029, 116 5,8-Dimethyl-2-[2-(1-methyl-4-pyrim...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.440 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144407 (US8969376, 1.111) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.460 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144413 (US8969376, 1.144 (Free)) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.480 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164549 (US9669029, 117 5,8-Dimethyl-2-[2-(1-methyl-4-pyraz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.520 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164283 (US9669029, 33 5-Methyl-2-[2-(4-thiophen-2-yl-1H-im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.540 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164560 (US9669029, 118 5,8-Dimethyl-2-[2-(1-methyl-4-pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144395 (US8969376, 1.019) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.570 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144400 (US8969376, 1.058) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.650 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144406 (US8969376, 1.109) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.780 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144389 (US8969376, 1.003 (HCl)) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 0.830 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144402 (US8969376, 1.062) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.870 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164284 (US9669029, 34 8-Methyl-2-[2-(4-thiophen-2-yl-1H-im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.990 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164391 (US9669029, 94 5,8-Dimethyl-2-[2-(1-methyl-4-thioph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphodiesterase (Bos taurus (Bovine)) | BDBM144416 (US8969376, 1.154) | PDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.08 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Mitsubishi Tanabe Pharma Corporation US Patent | Assay Description The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13... | US Patent US8969376 (2015) BindingDB Entry DOI: 10.7270/Q28P5Z7M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164354 (US9669029, 62 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164392 (US9669029, 95 8-Methoxy-5-methyl-2-[2-(1-propyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164543 (US9669029, 114 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164354 (US9669029, 62 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164396 (US9669029, 99 8-Methoxy-5-methyl-2-[2-(1-methyl-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164394 (US9669029, 97 4-{2-[2-(8-Methoxy-5-methyl-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164495 (US9669029, 103 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164316 (US9669029, 50 8-Methoxy-5-methyl-2-[(E)-2-(1-methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164501 (US9669029, 104 5,8-Dimethyl-2-[2-(1-methyl-4-thiaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [440-779] (Homo sapiens (Human)) | BDBM164350 (US9669029, 59 (R)-1-Chloro-3-{2-[2-(5-methyl-[1,2,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | 25 |
TBA US Patent | Assay Description The assay is performed in 60 uL samples containing a fixed amount of the relevant PDE enzyme (sufficient to convert 20-25% of the cyclic nucleotide s... | US Patent US9669029 (2017) BindingDB Entry DOI: 10.7270/Q2BG2M4J | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 197 total ) | Next | Last >> |